Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells.
A novel animal model involving chimeric mice with humanized livers established via human hepatocyte transplantation has been developed. These mice, in which the liver has been repopulated with functional human hepatocytes, could serve as a useful tool for investigating human hepatic cell biology, drug metabolism, and other preclinical applications. One of the key factors required for successful transplantation of human hepatocytes into mice is the elimination of the endogenous hepatocytes to prevent competition with the human cells and provide a suitable space and microenvironment for promoting human donor cell expansion and differentiation. To date, two major liver injury mouse models utilizing fumarylacetoacetate hydrolase (Fah) and uroplasminogen activator (uPA) mice have been established. However, Fah mice are used mainly with mature hepatocytes and the application of the uPA model is limited by decreased breeding. To overcome these limitations, Alb-toxin receptor mediated cell knockout (TRECK)/SCID mice were used for in vivo differentiation of immature human hepatocytes and humanized liver generation. Human hepatic stem cells (HpSCs) successfully repopulated the livers of Alb-TRECK/SCID mice that had developed lethal fulminant hepatic failure following diphtheria toxin (DT) treatment. This model of a humanized liver in Alb-TRECK/SCID mice will have functional applications in studies involving drug metabolism and drug-drug interactions and will promote other in vivo and in vitro studies.
Department of Regenerative Medicine, Graduate School of Medicine, Yokohama City University.
Ran-Ran
RR
Zhang
Department of Regenerative Medicine, Graduate School of Medicine, Yokohama City University; Department of Advanced Gastroenterological Surgical Science and Technology, Faculty of Medicine, University of Tsukuba; Regenerative Medicine Research Center, Jiangsu University Hospital; ywzheng@md.tsukuba.ac.jp.
Yun-Wen
YW
Zheng
Department of Regenerative Medicine, Graduate School of Medicine, Yokohama City University.
Hideki
H
Taniguchi
Stem Cell Res Ther. 2015 Mar 26;6:49
25889844
Biochem Biophys Res Commun. 2008 Dec 5;377(1):248-52
18840406
Nat Biotechnol. 2001 Aug;19(8):746-50
11479567
Stem Cells. 2007 Dec;25(12):3252-60
17885077
Biochem Biophys Res Commun. 2011 Feb 18;405(3):405-10
21238430
J Biol Chem. 1995 Jan 20;270(3):1015-9
7836353
J Pharmacol Exp Ther. 2013 Feb;344(2):388-96
23143674
Transplantation. 2007 Nov 27;84(10):1233-9
18049107
Trends Pharmacol Sci. 2013 May;34(5):255-60
23602782
Methods Mol Biol. 2010;640:491-509
20645070
Nat Biotechnol. 2007 Aug;25(8):903-10
17664939
Science. 1994 Feb 25;263(5150):1149-52
8108734
Gut. 2005 Jul;54(7):972-9
15951545
Cell Regen (Lond). 2013 Jan 22;2(1):1
25408873
Nature. 2014 Apr 3;508(7494):93-7
24572354
Am J Pathol. 2009 Oct;175(4):1483-92
19717639
Cell. 1992 Jun 12;69(6):1051-61
1606612
Clin Pharmacol Ther. 2008 Jun;83(6):818-28
18388875
Cell Transplant. 2008;17(3):313-23
18522234
Am J Pathol. 2004 Sep;165(3):901-12
15331414